linkedin share

Educational Case Study on Market Access in China Published

The recently published case study from Ebru Tekinturhan, Strategy Director at Axios International, and Reinhard Angelmar, Emeritus Professor of Marketing at INSEAD, looks at approaches to increase access to a high-cost metastatic renal cell cancer therapy in China utilizing Axios’ Creative Access Strategies – a unique approach that allows patients to pay only what they can afford and allows pharmaceutical companies to gain access to new customers that they would otherwise not have reached through more traditional business approaches.

Titled "Patient Access to Rencell in China," the case study is intended to be used as a basis for class discussion. 

To purchase the case study, click here

To learn more about Creative Access Strategies, contact Joseph Saba at Joseph.Saba@axiosint.com.